361 related articles for article (PubMed ID: 1455004)
1. Subcutaneous erythropoietin in the treatment of renal anaemia.
Drinovec J; Varl J
Przegl Lek; 1992; 49(1-2):38-40. PubMed ID: 1455004
[TBL] [Abstract][Full Text] [Related]
2. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis].
Lashutin SV; Nikolaev AIu; Ermolenko VM; Shutov EV; Bezruk VG; Ivashchenko MA
Ter Arkh; 1999; 71(6):61-3. PubMed ID: 10420460
[TBL] [Abstract][Full Text] [Related]
3. [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency].
Guízar JM; Gutiérrez MJ; Sánchez G; Kornhauser C
Rev Invest Clin; 1996; 48(3):173-7. PubMed ID: 8966377
[TBL] [Abstract][Full Text] [Related]
4. [Dosage of erythropoietin in children treated with hemodialysis and continuous ambulatory peritoneal dialysis].
Sieniawska M; Roszkowska-Blaim M
Pediatr Pol; 1995 Dec; 70(12):1023-8. PubMed ID: 8649941
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
Zelichowski G; Lubas A; Sienkiewicz M; Janusz E; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
Raja R; Bloom E; Johnson R
Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoreactive erythropoietin in patients with end stage renal disease.
Gimenez LF; Watson AJ; Spivak JL
Prog Clin Biol Res; 1990; 352():493-504. PubMed ID: 2402519
[No Abstract] [Full Text] [Related]
8. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
[TBL] [Abstract][Full Text] [Related]
9. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
Zehnder C; Blumberg A
Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110
[TBL] [Abstract][Full Text] [Related]
10. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
Cheng IK; Cy C; Chan MK; Yu L; Fang GX; Wei D
Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
[TBL] [Abstract][Full Text] [Related]
11. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
12. The use of subcutaneous erythropoietin in CAPD patients.
Piraino B; Johnston JR
Clin Nephrol; 1990 Apr; 33(4):200-2. PubMed ID: 2350907
[TBL] [Abstract][Full Text] [Related]
13. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous recombinant human erythropoietin in patients on CAPD.
Lye WC; Lee EJ
Adv Perit Dial; 1991; 7():285-7. PubMed ID: 1680447
[TBL] [Abstract][Full Text] [Related]
15. [Is it necessary to supplement with folic acid patients in chronic dialysis treated with erythropoietin?].
Duclos J; Sieberth HG; Mann H
Rev Med Chil; 1993 Jan; 121(1):30-5. PubMed ID: 8235161
[TBL] [Abstract][Full Text] [Related]
16. [The treatment of anemia in patients on hemodialysis with recombinant human erythropoietin].
Borrego FJ; Miguel JL; Zamorano A; Muñoz J; Bajo A; López-Revuelta K; Sánchez Sicilia L
Med Clin (Barc); 1991 Nov; 97(18):687-92. PubMed ID: 1770818
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.
Abreo K; Lubom JA; Collier L; Fleming D; Work J
Adv Perit Dial; 1994; 10():124-8. PubMed ID: 7999809
[TBL] [Abstract][Full Text] [Related]
18. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
[TBL] [Abstract][Full Text] [Related]
19. Increased need of erythropoietin during peritonitis in children on continuous peritoneal dialysis.
Amon O; Altrogge H; Kemper M; Strehlau J; Müller-Wiefel DE
Adv Perit Dial; 1994; 10():318-20. PubMed ID: 7999857
[TBL] [Abstract][Full Text] [Related]
20. [Erythropoietin treatment of dialysis patients].
Stenver DI; Nielsen B
Ugeskr Laeger; 1994 Apr; 156(17):2589-91. PubMed ID: 8016967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]